CervoMed Inc.
CRVO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $18,798 | $8,438 | $1,336 | $8,499 |
| G&A Expenses | $9,167 | $6,519 | $2,139 | $7,445 |
| SG&A Expenses | $9,167 | $6,519 | $2,139 | $7,445 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$9,738 | -$7,145 | $0 | $8,732 |
| Operating Expenses | $18,227 | $7,813 | $3,476 | $24,677 |
| Operating Income | -$18,227 | -$7,813 | -$3,476 | -$24,677 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,936 | $5,641 | -$2,328 | $137 |
| Pre-Tax Income | -$16,291 | -$2,172 | -$5,803 | -$24,540 |
| Tax Expense | $0 | $0 | $0 | -$444 |
| Net Income | -$16,291 | -$2,172 | -$5,803 | -$24,096 |
| % Margin | – | – | – | – |
| EPS | -2.02 | -0.82 | -11.2 | -18.51 |
| % Growth | -146.3% | 92.7% | 39.5% | – |
| EPS Diluted | -2.02 | -0.82 | -11.2 | -18.51 |
| Weighted Avg Shares Out | 8,073 | 2,661 | 518 | 1,302 |
| Weighted Avg Shares Out Dil | 8,073 | 2,661 | 518 | 1,302 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,937 | $219 | $62 | $137 |
| Interest Expense | $0 | $0 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $93 |
| EBITDA | -$18,227 | -$7,813 | -$5,802 | -$15,945 |
| % Margin | – | – | – | – |